# N-Acetylcysteine Augmentation in Treatment-Refractory Obsessive-Compulsive Disorder

> **NCT00539513** · PHASE2 · TERMINATED · sponsor: **Yale University** · enrollment: 10 (actual)

## Conditions studied

- Obsessive-Compulsive Disorder

## Interventions

- **DRUG:** N-Acetylcysteine
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00539513
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-06
- **Primary completion:** 2011-04
- **Final completion:** 2011-04
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** Researchers terminated study due to limited enrollment.
- **Last updated:** 2020-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00539513

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00539513, "N-Acetylcysteine Augmentation in Treatment-Refractory Obsessive-Compulsive Disorder". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00539513. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*